AzTrials
AzTrials

Limited English ProficiencyTACTNCT05502029

Translating Anesthesia Care Throughout

A study testing Extended translation and Standard translation in people with Limited English Proficiency and Perioperative Care, run by University of California, San Francisco at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Patients with limited English proficiency (LEP) are at significant risk of receiving care different from those who are English proficient. Through Translating Anesthetic Care Throughout (TACT), the investigators aim to reduce the disparities experienced by participants with LEP undergoing anesthesia by continuing… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
What is being tested?
Extended translation and Standard translation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
22 participants
Where
1 siteUnited States
Study dates
14 Feb 2023to 12 Jun 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Participants who identify another language other than English as their preferred language
  • Participants with planned general anesthesia

Who cannot join

  • Participants whose preferred language is documented as English
  • Participants with planned sedation or monitored anesthesia care

Trial locations and contacts

1 site in 1 country.

United States1 site
  • UCSF Medical Center at Mount Zion

    San Francisco, California, 94115

Other trials in United States

About this study

Official title: Translating Anesthetic Care Throughout: A Feasibility Randomized Trial

Patients with limited English proficiency (LEP) are at significant risk of receiving care different from those who are English proficient. Through Translating Anesthetic Care Throughout (TACT), the investigators aim to reduce the disparities experienced by participants with LEP undergoing anesthesia by continuing language translation from the preoperative area into the operating room, where participants will be better able to understand what is happening in an otherwise foreign environment. At this time, some participants receive translation in the preoperative area using an interpreter. No further translation is provided beyond the preoperative area unless there is a provider with language concordance or interpretation skills within the perioperative team. The investigators plan to study how extended translation changes a participant's understanding of and feelings about the perioperative period. Supporting language translation for LEP participants from the preoperative area into their operating room (OR) experience will enable providers to better understand how to care for participants from different cultural and language backgrounds and will help us understand how to better serve our community at large. The investigators hypothesize that participants who receive continual translation will have improved informed consent, have improved trust of their anesthesia providers, and be more satisfied with patient care. In addition, they anticipate that the care team also will benefit by the enhanced communication with the participant.

Being tested
Extended translation, Standard translation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Extended translationBehavioural

    Translation extended beyond the preoperative area

  • Standard translationBehavioural

    Translation in the preoperative area

Study groups in NCT05502029
Study groupRoleWhat they receive
ControlActive comparatorTranslator in preoperative area
Receives: Behavioral: Standard translation
InterventionExperimentalTranslator in preoperative area, continued through transport to the operating room, and in the operating room until the patient is under general anesthesia
Receives: Behavioral: Extended translation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Informed consent success as assessed by Likert scale

    The participant will be asked how well their anesthesia provider prepared them for their general anesthesia experience. A 5-point Likert scale response will be used for the assessment ranging from 1 (not at all) to 5 (extremely well).

    Measured: One week after general anesthesia

  2. Participant trust as assessed by survey

    Participants will be asked whether they trusted their provider(s) using a yes/no response.

    Measured: One week after general anesthesia

  3. Participant satisfaction as assessed by Likert scale

    Participants will be asked whether they were satisfied with their anesthesia experience using a yes/no response.

    Measured: One week after general anesthesia

Secondary outcomes (1)
  1. Participant anxiety as assessed by the Amsterdam Preoperative Anxiety and Information Scale

    The Amsterdam Preoperative Anxiety and Information Scale (APAIS) is a 6-question validated tool used to generate a score to assess a patient's level of preoperative anxiety. Questions 1, 2, 4, and 5 represent anxiety. Each of these questions is assessed with a Likert scale in which 1 rpresents agreement of not at all and 5 represents extremely. Scores from the four anxiety-representing questions are totaled with a possible range from 4 to 20 with a lower score indicating less anxiety and a higher score more anxiety. A score of greater than or equal to 11 signifies participant anxiety.

    Measured: The day before surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Aug 2022
  2. Study start14 Feb 2023
  3. Primary completion12 Jun 2023
  4. Study completion12 Jun 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
22 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05502029
Sponsor's protocol ID
22-36587
Acronym
TACT
Status last verified
Jul 2023
First submitted
12 Aug 2022
Last updated
1 Aug 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: This is a pilot study whose results are intended to inform the investigators of whether additional study is warranted.

Questions about this trial

What is this clinical trial studying?

A study testing Extended translation and Standard translation in people with Limited English Proficiency and Perioperative Care, run by University of California, San Francisco at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Aug 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Informed consent success as assessed by Likert scale (time frame: One week after general anesthesia). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Aug 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in